ISRCTN95819193已完成未知
Parasitologic impact of different mass drug administration strategies against Schistosoma mansoni in endemic areas of Mwanza Region, Tanzania, where prevalence is 25% or above
niversity of Georgia Research Foundation / SCORE (USA)0 个研究点目标入组 105,000 人开始时间: 2015年12月14日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 105,000
研究概览
简要总结
2016 Protocol article in http://www.ncbi.nlm.nih.gov/pubmed/27230666 protocol and baseline data 2020 Results article in https://pubmed.ncbi.nlm.nih.gov/32400356/ results (added 11/02/2021) 2017 Interim results article in https://doi.org/10.1186/s12879-017-2738-5 Protocol and baseline data for a multi-year cohort study of the effects of different mass drug treatment approaches on functional morbidities from schistosomiasis in four African countries (added 20/01/2023) 2020 Other publications in https://doi.org/10.4269/ajtmh.19-0805 Challenges in Protocol Development and Interpretation of the Schistosomiasis Consortium for Operational Research and Evaluation Intervention Studies (added 20/01/2023)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Schoolchildren, either male or female, aged 9-12 years, attending the selected schools (in each study year)
- •2. First-year students, either male or female, attending the selected schools (in years 1 and 5)
- •3. Written informed consent signed by parents or legal guardians of the schoolchildren
- •4. Oral assent from schoolchildren
- •5. At least one stool sample provided over three consecutive days from 9- to 12-year-old children each study year
- •6. At least one stool sample provided from first-year students and adults in years 1 and 5
排除标准
- •1. Children not aged 9-12 years (in years 2, 3 and 4)
- •2. Adults in Years 2, 3 and 4
- •3. Children under 9 in Years 2, 3 and 4
- •4. No written informed consent by parents or legal guardians of schoolchildren
- •5. No oral assent given by schoolchildren
- •6. No stool sample provided (for 9- to 12-year-old children in each study year; for first-year students and adults in years 1 and 5)
研究者
相似试验
已完成
不适用
Schistosoma Mansoni in Mwanza Region, TanzaniaSchistosoma MansoniNCT02162875DBL -Institute for Health Research and Development37,500
尚未招募
4 期
Assessment of combined antiparasitic drugs praziquantel and albendazole versus albendazole alone in the treatment of active parenchymal neurocysticercosis in Tanzania and Zambia.NeurocysticercosisPACTR202402822223203REvolution Worldwide S.r.l. Impresa Sociale300
已完成
1 期
Subcutaneous Daptomycin in Healthy Volunteers (DAPTOSC)AntibioticsSubcutaneous InjectionDaptomycinNCT04434300University Hospital, Caen12
已完成
3 期
ATAQ EASY: Artesunate + Amodiaquine Fixed Dose Combination in the Treatment of Uncomplicated Plasmodium Falciparum MalariaMalariaNCT00316329Sanofi1,032
招募中
不适用
Treatment of cutaneous leishmaniasis with pentamidine isethionate in Suriname; a comparison study between two treatment regimes, 3 days vs 7 days.NL-OMON23868Koninklijk Instituut voor de Tropen (KIT)220